Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 63–63 | Cite as

Brentuximab vedotin/nivolumab

Maculopapular rash: case report
Case report
  • 17 Downloads

Reference

  1. Tsvetkova L, et al. Nivolumab in combination with brentuximab vedotin in patients with relapsed or refractory Hodgkin's lymphoma after failure of nivolumab monotherapy. HemaSphere 2 (Suppl. 1): 169, Jun 2018. Available from: URL: http://doi.org/10.1097/HS9.0000000000000060 [abstract] -RussiaGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations